Equities

Solasto Corp

Solasto Corp

Actions
Health CareHealth Care Providers
  • Price (JPY)472.00
  • Today's Change-3.00 / -0.63%
  • Shares traded307.30k
  • 1 Year change-19.86%
  • Beta1.1102
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Solasto Corp is a Japan-based company mainly engaged in the medical-related contract business, and the nursing care and childcare business. The Company has two business segments. The Medical Related Contract segment is engaged in the provision of contract and staffing services such as reception, accounting, medical fee billing, hospital management support and other medical office related services. The Nursing Care And Childcare segment is engaged in the provision of home help services, day services, paid nursing homes with long-term care services, care houses, residential-type paid elderly homes, home care support services, group homes, home-visit nursing care services, childcare services, as well as the rental and sale of welfare equipment. The Company is also engaged in the provision of education and training services such as medical and nursing care related courses, the skill certification test business, the real estate leasing business, and the insurance agency business.

  • Revenue in JPY (TTM)136.54bn
  • Net income in JPY302.00m
  • Incorporated1968
  • Employees33.88k
  • Location
    Solasto Corp6F, DBC Shinagawa Tokyu Bldg1-7-18, KonanMINATO-KU 108-8210JapanJPN
  • Phone+81 334502610
  • Fax+81 338643655
  • Websitehttps://www.solasto.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CellSource Co Ltd4.45bn622.21m22.70bn151.0036.293.6830.795.1131.5831.58224.78311.550.74835.989.9429,442,380.0010.4719.2311.3722.5764.6470.7514.0020.2110.25--0.0012.895.5430.04-9.3036.7070.54--
Falco Holdings Co Ltd43.05bn1.83bn25.07bn1.12k13.370.93179.020.5825169.32169.323,990.492,428.931.1817.597.2538,538,940.005.025.796.417.9530.2731.284.254.662.29--0.020838.78-8.33-0.5259-26.3220.600.893711.70
Cyberdyne Inc4.39bn-1.18bn26.11bn227.00--0.9925--5.94-5.58-5.5820.81191.450.08732.227.7519,352,420.00-2.66-1.14-2.71-1.1652.6161.14-30.53-20.6814.00-10.610.0132--32.3820.57-395.30---22.40--
I'rom Group Co Ltd17.89bn258.00m32.03bn1.03k121.842.4921.771.7921.3121.311,477.811,044.220.5013.395.9917,387,760.000.7216.941.109.8739.6343.171.4411.341.1510.210.594831.02-3.3310.89-44.349.1816.6114.87
Sunwels Co Ltd23.37bn2.16bn33.39bn2.44k13.353.8310.871.4371.0171.01769.17247.450.88181,314.166.099,597,947.008.15--9.93--29.71--9.24--1.135.540.7342--55.72--159.16------
Charm Care Corp47.69bn4.45bn39.58bn2.03k8.902.157.320.83135.95135.951,458.21561.971.026.2315.0223,549,140.009.567.9217.9212.7418.1517.369.338.370.77997.630.424721.6626.2423.6333.3733.4744.0951.57
Elan Corp45.85bn2.46bn43.03bn378.0017.433.6114.280.938540.7340.73758.28196.492.4522.8510.01121,287,400.0013.1413.9022.0425.2723.0624.665.375.701.7253.110.010930.1514.2317.3920.9423.8213.7930.01
Solasto Corp136.54bn302.00m45.00bn33.88k147.032.0412.680.32963.233.231,476.44233.331.831,453.958.944,029,749.000.40375.400.59758.1816.4117.090.22122.941.3822.580.509254.163.099.91-28.85-8.4316.201.03
Value HR Co Ltd8.05bn782.07m50.94bn676.0063.127.7757.556.3329.4729.47302.25239.240.480882.0511.8111,903,510.004.674.836.736.7536.8040.549.7112.791.13--0.468551.7615.1114.6210.1331.90-40.8531.95
CUC Inc39.29bn3.57bn51.82bn3.74k14.211.819.001.32121.62121.621,340.36952.850.6091276.504.4210,496,660.005.52--6.40--48.98--9.06--2.49--0.539---6.21--7.10------
Data as of Nov 22 2024. Currency figures normalised to Solasto Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

17.64%Per cent of shares held by top holders
HolderShares% Held
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Feb 20243.22m3.39%
Norges Bank Investment Managementas of 30 Jun 20242.40m2.53%
Threadneedle Asset Management Ltd.as of 30 Sep 20241.87m1.97%
Nomura Asset Management Co., Ltd.as of 07 Nov 20241.72m1.82%
Columbia Wanger Asset Management LLCas of 30 Jun 20241.53m1.61%
The Vanguard Group, Inc.as of 06 Nov 20241.43m1.51%
Harding Loevner LPas of 30 Sep 20241.33m1.41%
Ichiyoshi Asset Management Co., Ltd.as of 05 Dec 20231.26m1.34%
Daiwa Asset Management Co. Ltd.as of 31 Oct 2024993.70k1.05%
Evli Fund Management Co. Ltd.as of 30 Sep 2024961.80k1.02%
More ▼
Data from 17 Jun 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.